• Publications
  • Influence
Early and Severe Hyperparathyroidism Associated with Hypercalcemia After Renal Transplant Treated with Cinacalcet
Bone disease is a common clinical problem following renal transplantation. In renal transplant recipients, multiple underlying factors determine the extent of bone loss and the subsequent risk ofExpand
  • 78
  • 4
Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure.
The histologic associations and clinical implications of peritubular capillary C4d staining from long-term renal allografts are unknown. We identified 99 renal transplant patients who underwent anExpand
  • 60
  • 3
  • Open Access
Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients.
BACKGROUND AND OBJECTIVES Leflunomide use in renal transplantation has been increasing. Outcome correlation and safety data are still to be refined. The goals of this study were to report oneExpand
  • 50
  • 3
  • Open Access
Racial Differences in Determinants of Live Donor Kidney Transplantation in the United States
Few studies have compared determinants of live donor kidney transplantation (LDKT) across all major US racial‐ethnic groups. We compared determinants of racial‐ethnic differences in LDKT among 208Expand
  • 37
  • 3
Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety.
BACKGROUND Corticosteroid therapy after renal transplantation is associated with many adverse effects. Newer immunosuppressive agents may allow for safe and effective reductions in dose or earlyExpand
  • 78
  • 2
Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study.
Long-term survival of kidney allografts is primarily limited by a progressive decline in function characterized by the presence of interstitial fibrosis (IF) and tubular atrophy (TA) on biopsy. SinceExpand
  • 17
  • 1
Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection
Background Antibody-mediated rejection (AMR) is a major cause of kidney allograft loss. Currently, AMR diagnosis relies on biopsy which is an invasive procedure. A noninvasive biomarker of acute AMRExpand
  • 11
  • 1
Maternal obesity is associated with congenital anomalies of the kidney and urinary tract in offspring
BackgroundCongenital abnormalities of the kidney and urinary tract (CAKUT) are diagnosed in up to 1 % of pregnancies and account for 20–30 % of the abnormalities identified in the prenatal period. InExpand
  • 17
  • 1
Mycophenolic Acid Pharmacokinetics During Maintenance Immunosuppression in African American and Caucasian Renal Transplant Recipients
Renal transplant recipients exhibit variability in mycophenolic acid (MPA) and MPA glucuronide (MPAG) pharmacokinetics, which are influenced by clinical and demographic factors. Racial influence onExpand
  • 22
  • 1
Donor-Recipient Size Matching Influences Early But Not Late Graft Function After Pediatric En-Bloc Kidney Transplantation
Background. Pediatric en-bloc kidney transplantation into adult recipients is an accepted technique to expand the donor pool. Concerns about adequate “nephron dosing” have traditionally favoredExpand
  • 17
  • 1